Carbonyl Reductase 3 Polyclonal Antibody

Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1.

The Carbonyl Reductase 3 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Carbonyl Reductase 3 (CBR3) protein expression. This antibody is produced using advanced techniques to ensure high affinity and sensitivity, enabling accurate and precise results in various applications.

The Carbonyl Reductase 3 Polyclonal Antibody exhibits exceptional specificity towards CBR3, making it an ideal choice for researchers and scientists working in the fields of biochemistry, molecular biology, and pharmacology. It has been extensively validated for use in Western blotting, immunohistochemistry, and immunofluorescence assays, providing consistent and reproducible results.

This antibody is manufactured using high-quality materials and undergoes rigorous quality control procedures to ensure batch-to-batch consistency and reliability. It is supplied as a liquid formulation, ready-to-use for immediate application, eliminating the need for time-consuming reconstitution.

With its superior performance and versatility, the Carbonyl Reductase 3 Polyclonal Antibody is an indispensable tool for studying the expression and function of CBR3 in various biological systems. Its exceptional sensitivity and specificity make it an invaluable asset for researchers aiming to unravel the intricate mechanisms underlying CBR3-related processes and diseases.

Choose the Carbonyl Reductase 3 Polyclonal Antibody for its exceptional quality, reliability, and performance, and unlock new insights into the role of CBR3 in cellular processes and disease pathogenesis.